ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,024Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 416

$1.71M Total Retail Price of All Prescriptions

Rank: 14 out of 416

478 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 12,889 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

57% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$131 was the average price of a prescription from this provider, compared to $166 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CELEBREX 763 762 1 11
AMLODIPINE BESYLATE 641 641 2 16
LIDODERM 456 455 3 19
METHOTREXATE 390 368 4 2
NEXIUM 381 381 5 31
ACTONEL 361 361 6 40
MELOXICAM 342 333 7 9
ATORVASTATIN CALCIUM 309 309 8 29
METFORMIN HCL 303 303 9 28
CLOPIDOGREL 296 296 10 70
DIOVAN HCT 279 279 11 47
SIMVASTATIN 275 275 12 14
DIOVAN 259 249 13 41
VOLTAREN 257 256 14 22
PLAVIX 225 225 15 74
ALENDRONATE SODIUM 220 220 16 5
CREON 194 194 17 66
JANUVIA 193 193 18 57
SINGULAIR 191 190 19 116
DOXAZOSIN MESYLATE 160 160 20 86
ATENOLOL 159 159 21 27
PREDNISONE 155 154 22 1
TAMSULOSIN HCL 149 149 23 54
LOVASTATIN 146 146 24 46
ZOLPIDEM TARTRATE 143 143 25 21
TEKTURNA 139 139 26 168
OMEPRAZOLE 136 135 27 10
LOSARTAN POTASSIUM 133 133 28 33
AZITHROMYCIN 131 131 29 60
EVISTA 130 130 30 55
LOSARTAN-HYDROCHLOROTHIAZIDE 124 124 31 65
GABAPENTIN 124 116 31 6
CRESTOR 123 121 33 58
NASONEX 116 116 34 159
BENICAR HCT 110 110 35 128
SULFASALAZINE 109 106 36 23
IBANDRONATE SODIUM 107 107 37 80
ISOSORBIDE MONONITRATE ER 104 104 38 122
ENBREL 103 91 39 8
FAMOTIDINE 97 97 40 91
METOPROLOL SUCCINATE 93 93 41 53
AVODART 88 88 42 132
BENICAR 86 86 43 123
HYDROXYCHLOROQUINE SULFATE 83 77 44 3
EXFORGE 79 79 45 113
HUMIRA 76 63 46 15
CLOTRIMAZOLE-BETAMETHASONE 74 73 47 160
ZETIA 74 74 47 103
LANSOPRAZOLE 72 72 49 130
ZENPEP 72 72 49 117
MONTELUKAST SODIUM 72 72 49 166
NAMENDA 71 71 52 110
ACIPHEX 70 70 53 153
TEKTURNA HCT 69 69 54 236
GLIPIZIDE 68 68 55 75
BONIVA 63 63 56 81
MECLIZINE HCL 62 62 57 193
FUROSEMIDE 58 58 58 35
GLYBURIDE-METFORMIN HCL 55 55 R 59 118
DONEPEZIL HCL 53 53 60 63
HYDROCODONE-ACETAMINOPHEN 50 48 S3 61 4
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.